In the complex world of nanomedicine, staying ahead of analytical challenges is a core focus of our work at Ardena. We are looking forward to taking this conversation further at our upcoming ‘Nanomedicine & Bioconjugation Symposium 2026’ this September.
As an organization, our guiding principle is “We Know Nano™,” reflecting our deep-rooted expertise in navigating the intricate challenges of nanomedicine development. Ardena’s first nanomedicine symposium brings together leading scientists, clinicians, and industry experts to discuss the latest advances in nanomedicine.
Over two days in Oss, The Netherlands, you will have the opportunity to hear from and engage directly with international key opinion leaders, industry innovators, and our own team of experts.
We are proud to feature speakers such as Dr. Christian Schröter (COO & Managing Director, Topas Therapeutics GmbH), who shares our vision for the event:
“I am looking forward to engaging with industry innovators and international leaders on the future of nanomedicine. It is a pleasure to contribute to these discussions. Thanks to the entire team at Ardena for organizing such a significant event that addresses our shared scientific challenges.”
The symposium is designed for C-level executives, CMC experts, and senior scientists from biotech, pharma, and academia who are navigating the evolving landscape of complex drug development. Our speaker panel focuses on four critical pillars of modern nanomedicine:
- Nanomedicines in clinical development
- Bioconjugation
- mRNA / LNP formulation strategies
- Analytical characterisation of complex modalities
Whether your work involves navigating regulatory hurdles, refining formulation strategies, or mastering advanced analytical characterization, this symposium offers a unique platform to exchange knowledge and gain practical insights.
Beyond the sessions, attendees will also have the exclusive opportunity to tour Ardena’s specialized nanomedicine facility, providing a first-hand look at the integrated workflows that drive successful development.
Join us in Oss on 15-16 September 2026.
Register for the ‘Nanomedicine & Bioconjugation Symposium 2026’ here
